Healthcare and Medical

Proton Therapy Market To Reach US$2,763.2 Million By 2023

Ashish Thapa

Proton Therapy Market To Reach US$2,763.2 Million By 2023

Market Overview:

Proton therapy is a type of radiation therapy that uses proton beams to treat cancer. It offers advantages over conventional radiation therapy, such as better targeting of tumors and reduced damage to healthy tissues. The need for proton therapy is driven by the increasing incidence of cancer and the growing preference for non-invasive treatment options. Proton therapy has shown promising results in the treatment of various types of cancer, including brain tumors, prostate cancer, and pediatric cancers.

Market Key Trends:

Proton therapy has gained significant attention in the healthcare industry due to its precision and effectiveness in targeting tumors. One key trend driving the market growth is the technological advancements in proton therapy systems. The demand for more advanced and efficient proton therapy systems has led to the development of compact and cost-effective machines that offer improved accuracy and patient comfort.

Moreover, the increasing adoption of proton therapy by healthcare providers is another key trend in the market. The benefits of proton therapy, such as reduced side effects and better quality of life for cancer patients, have led to its widespread adoption in various healthcare facilities across the globe. This trend is expected to continue as more research evidence supports the effectiveness of proton therapy and as the technology becomes more accessible.

In conclusion, the proton therapy market is projected to experience significant growth in the coming years. Technological advancements and increasing adoption of proton therapy are expected to drive market expansion. Additionally, the rising prevalence of cancer and the need for non-invasive treatment options are contributing to the market's growth.

The global Proton Therapy Market Size is estimated to be valued at US$2,763.2 Mn in 2023 and is expected to exhibit a CAGR Of 13.0% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Segment Analysis:

The proton therapy market can be segmented based on treatment type, indication, and end-user. Based on treatment type, the market can be divided into single-room systems and multi-room systems. The multi-room systems segment is expected to dominate the market during the forecast period. This is due to the advantages offered by multi-room systems, such as the ability to treat multiple patients simultaneously, reduced treatment time, and cost-effectiveness. Multi-room systems also offer greater flexibility in terms of treatment planning and precision.

Key Takeaways:

The global proton therapy market is expected to witness high growth, exhibiting a CAGR of 13.0% over the forecast period of 2023-2030. This growth can be attributed to increasing cancer prevalence worldwide, advancements in technology enabling precise treatment delivery, and the growing adoption of proton therapy by healthcare providers.

In terms of regional analysis, North America is expected to be the fastest-growing and dominating region in the proton therapy market. This can be attributed to the presence of advanced healthcare infrastructure, increasing government initiatives to promote proton therapy, and rising awareness about the benefits of proton therapy among patients and healthcare professionals in the region.

Key players operating in the proton therapy market include Hitachi Ltd., Ion Beam Applications S.A, Mevion Medical Systems, Mitsubishi Electric Corporation, Provision Healthcare, ProTom International, Sumitomo Heavy Industries, Varian Medical Systems, Optivus Proton Therapy, Inc., and Advanced Oncotherapy plc. These key players are actively involved in strategic partnerships, collaborations, and acquisitions to expand their market presence and offer advanced proton therapy solutions to customers. They are also investing in research and development activities to enhance their product offerings and gain a competitive edge in the market.

Ashish Thapa

Proton Therapy Market Growth Accelerated by Emerging Economies

Mia Yates 2024-01-09

The adoption of proton therapy is increasing rapidly as it offers substantial clinical advantages. The global proton therapy market is estimated to be valued at US$ 2763. Moreover, these emerging economies are increasingly prioritizing healthcare infrastructure development which is accelerating the adoption of advanced cancer treatment modalities like proton therapy. Segment Analysis The global proton therapy market can be segmented based on product into cyclotrons, synchrotrons, and synchrocyclotrons. Synchrotrons are the most commonly used devices for proton therapy as they provide uniform radiation intensity and sufficient dose rates for patient treatments.

The integration of artificial intelligence projected to boost the growth of Proton Therapy Market

Gauri Cmi 2023-11-29

The global Proton Therapy Market is estimated to be valued at US$ 2,763. The devices used in proton therapy work by accelerating protons to high energies and directing them into the tumor using magnets. With ongoing advancements in artificial intelligence and machine learning, proton therapy providers are integrating these technologies with treatment planning and delivery systems. For instance, AI-powered motion management helps track tumor motion in real-time and adjusts the proton beam accordingly for enhanced accuracy. Regional analysis: North America dominates the global proton therapy market.

Proton therapy is a type of radiation therapy that treats cancer and some noncancerous lesions with high-powered energ

Pooja salve 2022-03-21

Because doctors can better control where proton beams transmit their energy, studies have suggested that proton treatment may produce less side effects than standard radiation. However, because there have been few studies comparing proton and X-ray radiation, it's unclear whether proton treatment is more effective at extending life. Furthermore, the market is likely to rise as the number of healthcare facilities delivering proton therapy grows. If the cancer persists or returns after standard X-ray radiation, proton therapy may be employed. The side effects you encounter will be determined by the area of your body being treated and the proton therapy dose you get.

Global Proton Therapy Market to Reach US$ 77 Billion by 2027

Prateek Baranwal 2022-03-02

According to the latest report by Renub Research “Proton Therapy Market Size, Share, Global Forecast 2022-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis” the Global Proton Therapy Market Size was US$ 68. Factors Fuelling the Growth of the Global Proton Therapy Market:The growth of the proton therapy market across the world is mainly driven by rising healthcare expenditure, expanding preference for advanced therapies by healthcare practitioners, increasing confirmation, and increasing cancer pervasiveness. phpThe United States has the Largest Number of Proton Therapy Centres Globally:The United States is the proton therapy industry's hub, having the highest number of proton therapy hubs globally. The major players in the Global Proton Therapy Market studied in our report are IBA Proton Therapy, Varian Medical Systems, and Elekta. phpCOVID-19 Impact on Global Proton Therapy Industry:Despite the outbreak of COVID-19 worldwide, the proton therapy market has expanded at a constant rate.

Proton Therapy Adoption Growth Accelerated by Improving Reimbursement Policies

Sneha 2023-12-15

However, proton therapy equipment and treatment costs are higher compared to traditional X-ray radiation therapy. The global Proton Therapy Market is estimated to be valued at US$ 2,763. As clinical evidence demonstrating the advantages of proton therapy accumulates, major insurance providers and public healthcare programs are increasingly recognizing proton therapy as a standard treatment option. This growing reimbursement favorability is projected to boost the installation of new proton therapy centers worldwide in the coming years. This can be attributed to factors such as presence of advanced healthcare infrastructure, favorable reimbursement policies for cancer treatment, and growing adoption of innovative technologies for cancer treatment in the region.

Global Proton Therapy Market Is Estimated To Witness High Growth Owing To Increasing Adoption of Proton Therapy in Cancer Treatment

Vaishnavi Kashid 2023-08-25

The global Proton Therapy Market is estimated to be valued at US$ 2,763. B) Market Key Trends: One key trend in the global proton therapy market is the increasing adoption of proton therapy in pediatric oncology. C) PEST Analysis: - Political: Government initiatives and regulations supporting the adoption of proton therapy for cancer treatment are driving market growth. D) Key Takeaways: - The global Proton Therapy Market is expected to witness high growth, exhibiting a CAGR of 13. In conclusion, the global proton therapy market is witnessing high growth due to the increasing adoption of proton therapy in cancer treatment.

WHO TO FOLLOW

MORE FROM AUTHOR

Foldable Container House Market To Grow At Highest Pace Owing To Increasing Demand For Prefab Homes

Ashish Thapa 2024-02-26

Tequila Market Growth To Be Driven By Rising Demand For Premium And Super Premium Tequila Products

Ashish Thapa 2024-02-26

PTFE Market Will Grow At Highest Pace Owing To Increasing Demand From End-Use Industries

Ashish Thapa 2024-02-26

The Global Shared Services Provide Advantages Owing To Growing Digitization

Ashish Thapa 2024-02-26

Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.

Press enter to search

Proton Therapy Market Is Estimated To Witness High Growth Owing To Need To Reduce Side Effects

Poonam 2023-12-28

The global proton therapy market is estimated to be valued at US$ 2763. Key Takeaways The global Proton Therapy Market Share is expected to witness high growth during the forecast period of 2023 to 2030. Regional analysis of the proton therapy market comprises fastest growth in the Asia Pacific region majorly attributed to increasing awareness and expanding healthcare infrastructure. Countries like China, India, and Japan are likely to offer significant opportunities in the proton therapy market. Key players operating in the proton therapy market are Bayer AG, Boehringer Ingelheim GmbH, Cargill Inc.

Particle Therapy Market Worth $1,349 million by 2023 – Global Industry Leaders & Growth Divers Adopted

Sasha Sharma 2020-12-04

According to the new market research report by MarketsandMarkets, the global particle therapy market is projected to reach USD 1,349 million by 2023 from USD 865 million in 2018, at a CAGR of 9.3%.Growth in the Proton Therapy market is primarily driven by factors such as the various advantages offered by particle therapy over photon therapy, growing global prevalence of cancer, increasing adoption of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide.Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=12809137The particle therapy market comprises several stakeholders such as particle therapy product manufacturers, suppliers and distributors, healthcare service providers, and research institutes.

The demand side of this market is characterized by the increasing awareness about minimally invasive cancer treatment options and the global rise in the prevalence of cancer.The Geographical Landscape of the Proton Therapy Include:The Asia Pacific is one of the major revenue generating regions in the Proton Therapy.

China and Japan are the major countries responsible for the high growth of this regional market owing to factors such as the increasing per capita income, improving healthcare infrastructure, and supportive government activities in these emerging countries.

Furthermore, the increasing geriatric population, growing incidence of cancer, and rising acceptance of particle therapy procedures and devices are also driving the growth of this regional market.Get 10% Customization on this Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=12809137Synchrotrons are used to accelerate both protons and heavy ions such as carbon and hydrogen.

The growth of the synchrotrons segment is attributed to factors such as the increasing number of research activities as well as the increasing investments in the development of synchrotron facilities.The large share of the proton therapy segment can be attributed to factors such as the high degree of precision, shorter treatment time, and reduced side-effects associated with proton therapy as compared to conventional photon therapies using X-rays.

Other factors such as the increasing research activities in the field of radiation oncology using proton therapy systems, rising number of proton therapy centers, and longer equipment lifespan of proton therapy (30 years or more) in comparison to photon therapy (10 years) are expected to support the growth of this market in the coming years.The introduction of small footprint single-room particle therapy centers is further promoting the adoption of proton therapy for the treatment of cancer in small-scale hospitals.

Proton Therapy Market New Opportunities, Segmentation Details with Financial Facts By 2028

Shubham Gurav 2020-02-06

Proton Therapy Market Research Report includes a comprehensive review of key drivers, market leaders, major segments and regions.

This study also notes that the Proton Therapy Market is expected to rise steadily in the coming years from 2020-2028.

The report presents a sorted image of the Proton Therapy Market industry by providing an analysis of the study and data from various sources.Click here to get a sample of the premium report @ https://www.quincemarketinsights.com/request-sample-57966?utm_source=Offpage_medium=SG_campaign=SGCrucial perspectives outlined in the study such as competitive scenario, leading market players, a summary of the supply chain, product specifications, manufacturing processes, drivers and constraints, cost structures would certainly benefit market players in formulating potential plans to grow their companies.Assessment of Proton Therapy Market:The report provides a sector framework summary with descriptions and classifications.

The report provides a detailed overview of the growth rate of each segment, recent developments, in-depth analysis of key market players operating on the Proton Therapy Market sector, with the aid of charts and tables.

Besides this, a comprehensive analysis of each application's consumption, market share, and growth rate is offered over the historical period.

The report then introduced a new SWOT analysis project, an analysis of investment feasibility and an analysis of return on investment.

Cancer Therapy Market Growth Accelerated by Rapid Adoption of Novel Therapies

Ishika cmi 2024-02-06

The global Cancer Therapy Market is estimated to be valued at US$ 231671. If approved, these novel drug candidates are expected to get adopted at a larger scale, thereby propelling the market growth during the forecast period. Segment Analysis The global cancer therapy market is dominated by chemotherapy sub segment accounting for around 30% share of the total market. Regional analysis: North America dominates the global cancer therapy market and is anticipated to maintain its leading position during the forecast period as well. Higher adoption of advanced cancer therapies along with presence of well-established healthcare industry and favorable reimbursement policies are some factors driving the cancer therapy market growth in the region.

Proton Therapy Market Global Industry Size, Share, Demand, Growth Analysis and Forecast By 2028

Sagar Vaidya 2022-12-01

Also, market share analysis and key trend analysis are the major accomplishing factors in the world class Proton Therapy market document. The supreme Proton Therapy market research report is constructed with the professional and in-depth study of Proton Therapy industry by keeping in mind the customer requirement. The major limitations of photon therapy or other particle therapy are overcome by the proton therapy. Table of Content: Proton Therapy MarketIntroductionMarket SegmentationExecutive SummaryPremium InsightsMarket OverviewGlobal Proton Therapy Market, By Deployment TypeGlobal Proton Therapy Market, By ComponentGlobal Proton Therapy Market, By Organization SizeGlobal Proton Therapy Market, By VerticalGlobal Proton Therapy Market, By RegionGlobal Proton Therapy Market, Company LandscapeSwot AnalysisCompany ProfileQuestionnaireRelated ReportsFor More Insights Get Detailed TOC @ https://www. dbmr=global-proton-therapy-marketBrowse Trending Reports:Anti Aging Services Market Size, Share, Growth and Opportunities https://www.

A Comprehensive Guide to Proton Beam Therapy: Understanding the Treatment Process and what to Expect

Edha Care 2023-11-03

The treatment process for proton beam therapy in India typically involves several steps:1. Unlike conventional radiation therapy, which uses x-rays, proton beam therapy allows for greater precision in delivering radiation to the tumor while minimizing exposure to nearby healthy tissues. Reduced side effects: Due to its precision, proton beam therapy may cause fewer side effects compared to conventional radiation therapy. However, the risk and severity of side effects with proton beam therapy are generally lower compared to conventional radiation therapy. Common side effects of proton beam therapy may include:Fatigue: Feeling tired or lacking energy is a common side effect of radiation therapy.

Oxygen Therapy Market Anticipated to Witness High Growth Owing to Rising Prevalence of Respiratory Diseases

Sumedha 2024-02-13

The oxygen therapy market involves the provision of oxygen when oxygen levels within the body are too low. The Global Oxygen Therapy Market is estimated to be valued at US$ 42. Key Takeaways Key players operating in oxygen therapy market are Schmitz Cargobull, China International Marine Containers (Group) Ltd. Technological advancement in oxygen therapy delivery devices such as lightweight, high-density, and portable oxygen concentrators is pushing the market boundaries. Impact of COVID-19 on the Oxygen Therapy Market The outbreak of COVID-19 pandemic has significantly impacted the growth of the oxygen therapy market globally.

Neuroregeneration Therapy Market Growth Accelerated by Increasing Incidences of Neurological Disorders

Niranjan Mardakar 2024-02-05

The global neuroregeneration therapy market is estimated to be valued at US$ 13. Segment Analysis The global neuroregeneration therapy market is dominated by central nervous system segment as it holds the largest share. Key TakeawaysThe global neuroregeneration therapy market is expected to witness high growth. Regional analysis: The North American region presently dominates the global neuroregeneration therapy market. Key players operating in the neuroregeneration therapy market are Boeing, General Atomics, Israel Aerospace Industries Ltd, Northrop Grumman and Lockheed Martin Corporation.

Unexpected Growth Seen in the U.S. Proton Therapy Market

Maria Rai 2020-10-29

The exclusive research report on the United States Proton Therapy Market examines the market in detail along with focusing on significant market dynamics for the key players operating in the market.

United States Proton Therapy Industry research report offers granulated yet in-depth analysis of revenue share, market segments and revenue estimates.Download Free Sample Report @ https://dpiresearch.com/request-a-free-sample-report“The United States Proton Therapy Market (Actual & Potential), Patients Treated, Reimbursement, Clinical Trials, Proton Therapy Centers, Major Deals, Key Company Profiles & Demand Forecasts to 2018 – 2025”presents an in-depth assessment of the proton therapy market dynamics,opportunities, future roadmap, competitive landscape and discusses major trends.

The report offers the most up-to-date industry data on the actual and potential market situation and future outlook for Proton Therapy in the United States.

The research includes historic data from 2012 to 2017 and forecasts until 2025.Long–term Growth Projection:United States proton therapy market will exhibit growth by a CAGR of over 15% up to 2025United States is anticipated to be the most attractive market in the proton therapy market industryThe potential United States proton therapy market is set to cross USD 7 Billion by 2025In 2017, IBA accounted the highest number of proton therapy centers in the United StatesHitachi has the second highest number of treatment rooms in the United StatesThe report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, volume, revenues and provides forecasts through 2025.

In addition, the report also provides essential insights into the number of patients treated at US proton therapy centers.The report also includes an assessment of US reimbursement scenario, proton therapy clinical trials and offers a clear view of the proton therapy center component analysis.

The key market players are evaluated on various parameters such as company overview, product portfolio, US proton therapy centers developed by the companies, recent development & trends of the proton therapy market.The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:Hitachi, Optivus, Ion Beam Applications(IBA), Varian Medical Systems, Mevion Medical SystemsThe Latest Industry Data Included in this Report:Proton Therapy Market Size & Analysis(2012 – 2025)Proton Therapy Market Opportunity Assessment(2012 – 2025)Number of Treatment Rooms and Forecast (2012 – 2025)Proton Therapy Center (Installed Base) and Treatment Room Market Share: By CompanyProton Therapy Center Infrastructure Analysis: Treatment Rooms & Proton Therapy AcceleratorMajor Deals in Proton Therapy MarketNumber of Patients Treated at Proton Therapy CenterProton Therapy Reimbursement ScenarioProton Therapy Current ApplicationsPros and Cons of Proton Therapy, Radiotherapy, and Carbon Ion TherapyProton Therapy Competitive Analysis: By CompanyProton Therapy Center Component AnalysisProton Therapy Clinical Trial Insight by Phase, Institute & CountryKey Market Drivers and InhibitorsMajor Companies AnalysisFor More Information@ https://dpiresearch.com/reports/united-states-proton-therapy-market/The report is readily available and can be dispatched immediately after payment confirmation.Would like to place an order or any question, please feel free to contact at [email protected] of the Report:DPI Research provides customization of the report as per your need.

Proton Pump Inhibitors is fastest growing segment fueling the growth of Proton Pump Inhibitors Market

naufan 2023-12-14

They provide effective relief from heartburn and acid reflux by blocking the action of gastric acid pumps in the stomach wall. The proton pump inhibitors market is estimated to be valued at US$ 3. Segment Analysis The global Proton Pump Inhibitors market is dominated by the omeprazole sub-segment. Omeprazole accounts for over 30% of the global market share owing to its high efficacy in treating conditions like acid reflux and peptic ulcers. 3% over the forecast period, due to increasing prevalence of acid reflux diseases and peptic ulcers.

Proton Pump Inhibitors Market Growth is Accelerated by Increasing Prevalence of GERD and Peptic Ulcers

Purvaja 2024-01-02

The global Proton Pump Inhibitors Market is estimated to be valued at US$ 3. GERD, commonly known as acid reflux, is a common condition where stomach acid backs up into the esophagus. Their widespread use to treat disorders associated with excess stomach acid has contributed significantly to the increasing demand and growth of the proton pump inhibitors market. Segment Analysis The global proton pump inhibitors market is dominated by the pharmaceutical segment. Regional analysis: North America is expected to continue dominating the proton pump inhibitors market during the forecast period.

Proton Therapy Market Provides An In-Depth Insight Of Sales And Trends Forecast To 2026

Sunil Rathod 2020-07-13

In this report, our team offers a comprehensive analysis of Proton Therapy market, SWOT analysis of the most prominent players in this landscape.

Along with an industrial chain, market statistics in terms of revenue, sales, price, capacity, regional market analysis, segment-wise data, and market forecast information are offered in the full study, etc.

Download Free Sample Report @ https://www.radiantinsights.com/research/global-proton-therapy-market-2020-2026/request-sample This report focuses on top manufacturers in global market, Involved the assessment of Sales, price, revenue and market share for each manufacturer, covering• IBA• Mitsubishi• Optivus• Hitachi• Mevion• Varian• ProNova• Sumitomo On the basis of product, this report displays the Sales, revenue, price, market share and growth rate of each type, primarily split into• Equipment• Drugs By Application, this report focuses on Sales, Market share and Growth Rate of each application, can be divided into• Tumor Therapy• Others By Regions, this report splits global market into several key regions, with Sales, Revenue, Price and Gross Margin market share of top players in these regions, from 2014 to 2026 (forecast), like• China• USA• Europe• Japan• Korea• India• Southeast Asia• South America Browse Full Research Report with TOC @ https://www.radiantinsights.com/research/global-proton-therapy-market-2020-2026 Table of Contents Global Proton Therapy Market Professional Survey Report 20191 Report Overview1.1 Definition and Specification1.2 Manufacturers and Region Overview1.2.1 Manufacturers Overview1.2.2 Regions Overview1.3 Type Overview1.3.1 Equipment1.3.2 Drugs1.4 Application Overview1.4.1 Tumor Therapy1.4.2 Others1.5 Industrial Chain1.5.1 Proton Therapy Industrial Chain1.5.2 Upstream1.5.3 Downstream 2.1 The Overall Market Performance(Volume)2.1.1 Equipment2.1.2 Drugs2.2 The Overall Market Performance(Value)2.2.1 Equipment2.2.2 Drugs 3 Global Proton Therapy Market Assessment by Application3.1 Overall Market Performance (Volume)3.2 Tumor Therapy3.3 Others 4 Competitive Analysis4.1 IBA4.1.1 IBA Profiles4.1.2 IBA Product Information4.1.3 IBA Proton Therapy Business Performance4.1.4 SWOT Analysis4.2 Mitsubishi4.2.1 Mitsubishi Profiles4.2.2 Mitsubishi Product Information4.2.3 Mitsubishi Proton Therapy Business Performance4.2.4 SWOT Analysis4.3 Optivus4.3.1 Optivus Profiles4.3.2 Optivus Product Information4.3.3 Optivus Proton Therapy Business Performance4.3.4 SWOT Analysis Continued… Read all Reports of this category @ https://www.radiantinsights.com/catalog/pharmaceuticals-and-healthcare About Radiant InsightsRadiant Insights is a platform for companies looking to meet their market research and business intelligence requirements.

It assists and facilitate organizations and individuals procure market research reports, helping them in the decisions making process.

The Organization has a comprehensive collection of reports, covering over 40 key industries and a host of micro markets.

In addition to over extensive database of reports, experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

The Potential Risks And Side Effects Of Proton Pump Inhibitors

sachin sadgir 2023-07-14

While Proton Pump Inhibitors (PPIs) offer significant benefits in managing acid-related disorders, it's essential to be aware of their potential risks and side effects. Additionally, there is evidence linking Proton Pump Inhibitors use with an increased risk of certain infections, including pneumonia and Clostridium difficile-associated diarrhea. Another potential side effect of PPIs is an increased risk of bone fractures, particularly in older individuals. Understanding their mechanism of action, clinical uses, and potential side effects allows patients and healthcare providers to make informed decisions regarding treatment. By unraveling the complexities surrounding proton pump inhibitors, patients can navigate their treatment journey more confidently.

Non-Small Cell Lung Cancer Market is Expected to Increase With a CAGR of 10.7% for the Study Period of 2017-2030: DelveInsight

Ankit Nigam 2020-10-12

Non-Small Cell Lung Cancer Market is Expected to Increase With a CAGR of 10.7% for the Study Period of 2017-2030: DelveInsight (Albany, US) DelveInsight has introduced a new Market Insights, Epidemiology, and Market Forecast Report on "Non-Small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast-2030" to its portfolio.Key Highlights from report are:As per the DelveInsight analysis, the total incident cases of NSCLC in the 7MM were observed to be 484,726 cases in the year 2017.

These cases are expected to grow with a significant CAGR in the study period 2017–2030.There are different types of treatment available for NSCLC; however, mainly 10 types of standard treatment are used, which include Surgery, Radiation therapy, Chemotherapy, Targeted therapy, Immunotherapy, Laser therapy, Photodynamic therapy (PDT), Cryosurgery, Electrocautery, and Watchful waiting.The market size of NSCLC in the 7MM is expected to increase during study period.

According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.One of the most exciting developments in lung cancer medicine is the introduction of targeted treatments.Request for free sample pages to know more on Non-Small Cell Lung Cancer Market Forecast NSCLC is the most common type of lung cancer accounted for approximately 85% of all lung cancers.

The disease epidemiology included in the report provides historical as well as forecasted Non-Small Cell Lung Cancer epidemiology, which is segmented as Total Incident cases of NSCLC patients, Total Incident cases of NSCLC patients by Histology, Total Diagnosed cases of NSCLC patients by Stages, Total NSCLC cases of patients by Genetic mutation/Biomarkers, and Total Treated Cases of NSCLC patients by Line of Therapies scenario of NSCLC in the 7MM.The total NSCLC incident cases in the 7MM were observed to be 484,726 cases in 2017.Click here to know more on Non-Small Cell Lung Cancer pipelineNSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.

The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.Drugs covered in the report are:-There are several key players robustly involved in developing potential products such asNazartinib (EGF816)Capmatinib (INC280)Tepmetko (tepotinib)MerestinibJNJ-61186372 (JNJ-6372)Vemurafenib Plus CobimetinibX-396 (Ensartinib)Tedopi (OSE2101)Selpercatinib (LY3527723/ LOXO-292)SAR408701Braftovi (encorafinib) + Mektovi (binimetinib)PADCEV (enfortumab vedotin/ASG-22ME)Pralsetinib (BLU-667)TAK-788: Canakinumab (ACZ885)Avelumab (Bavencio)Veliparib (ABT-888): Sitravatinib (MGCD516)TesevatinibRomiplostim: CabozantinibSym015AMG 510INCMGA00012 (MGA012)Libtayo (Cemiplimab)BavituximabM7824 (Bintrafusp alfa)And many others Key Players covered in the report are:-Novartis PharmaceuticalsMerck KGaAEli Lilly and CompanyJanssen Research & DevelopmentHoffmann-La RocheXcoveryBeyondSpring PharmaceuticalsOSE ImmunotherapeuticsSanofiPfizerAstellas PharmaSeattle GeneticsBlueprint Medicines CorporationTakedaAbbVieKadmon CorporationAmgenSymphogenRegeneron PharmaceuticalsPeregrine PharmaceuticalsAvid BioservicesGlaxoSmithKlineAnd many othersThe report includes provides in depth analysis historical and forecasted Market Share (%) Distribution of NSCLC, Market Share (%) Distribution of NSCLC by Mutations/Biomarkers, Total Market Size of PD-L1 NSCLC, Total Market Size of BRAF NSCLC, Total Market Size of c-Met, Total Market Size of EGFR, Total Market Size of ALK as well.The reasons for buying this report:The report proffers an overview of pathophysiology, various diagnostic approaches and NSCLC treatment algorithm, including detailed chapters for marketed products and emerging therapies.Historical and forecasted Non-Small Cell Lung Cancer epidemiology in 7MM covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017-2030.Detailed historical and forecasted NSCLC market covering the United States, EU5 and Japan from 2017-2030.

Pipeline analysis across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with comprehensive clinical profiles, key cross-competition, launch date along with product development activities.

Proton Therapy Market Is Estimated To Witness High Growth Owing To Need To Reduce Side Effects

Poonam 2023-12-28

Unexpected Growth Seen in the U.S. Proton Therapy Market

Maria Rai 2020-10-29

The exclusive research report on the United States Proton Therapy Market examines the market in detail along with focusing on significant market dynamics for the key players operating in the market.

The report offers the most up-to-date industry data on the actual and potential market situation and future outlook for Proton Therapy in the United States.

Particle Therapy Market Worth $1,349 million by 2023 – Global Industry Leaders & Growth Divers Adopted

Sasha Sharma 2020-12-04

Proton Pump Inhibitors is fastest growing segment fueling the growth of Proton Pump Inhibitors Market

naufan 2023-12-14

Proton Therapy Market New Opportunities, Segmentation Details with Financial Facts By 2028

Shubham Gurav 2020-02-06

Proton Therapy Market Research Report includes a comprehensive review of key drivers, market leaders, major segments and regions.

This study also notes that the Proton Therapy Market is expected to rise steadily in the coming years from 2020-2028.

Besides this, a comprehensive analysis of each application's consumption, market share, and growth rate is offered over the historical period.

The report then introduced a new SWOT analysis project, an analysis of investment feasibility and an analysis of return on investment.

Proton Pump Inhibitors Market Growth is Accelerated by Increasing Prevalence of GERD and Peptic Ulcers

Purvaja 2024-01-02

Cancer Therapy Market Growth Accelerated by Rapid Adoption of Novel Therapies

Ishika cmi 2024-02-06

Proton Therapy Market Global Industry Size, Share, Demand, Growth Analysis and Forecast By 2028

Sagar Vaidya 2022-12-01

Proton Therapy Market Provides An In-Depth Insight Of Sales And Trends Forecast To 2026

Sunil Rathod 2020-07-13

In this report, our team offers a comprehensive analysis of Proton Therapy market, SWOT analysis of the most prominent players in this landscape.

It assists and facilitate organizations and individuals procure market research reports, helping them in the decisions making process.

The Organization has a comprehensive collection of reports, covering over 40 key industries and a host of micro markets.

In addition to over extensive database of reports, experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

A Comprehensive Guide to Proton Beam Therapy: Understanding the Treatment Process and what to Expect

Edha Care 2023-11-03

The Potential Risks And Side Effects Of Proton Pump Inhibitors

sachin sadgir 2023-07-14

Oxygen Therapy Market Anticipated to Witness High Growth Owing to Rising Prevalence of Respiratory Diseases

Sumedha 2024-02-13

Non-Small Cell Lung Cancer Market is Expected to Increase With a CAGR of 10.7% for the Study Period of 2017-2030: DelveInsight

Ankit Nigam 2020-10-12

Neuroregeneration Therapy Market Growth Accelerated by Increasing Incidences of Neurological Disorders

Niranjan Mardakar 2024-02-05